All In Biotech

Free tool

FAERS Monitor: Valtrex

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 020550 or its brand name (Valtrex, Valacyclovir Hydrochloride). Reports on generic versions are filed under their own applications.

Reports

46,257

Serious

33,410

72% of reports

Hospitalization

18,492

Death reported

3,756

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug ineffective2,802
  • nausea2,783
  • fatigue2,678
  • off label use2,480
  • diarrhoea2,261
  • headache2,071
  • pyrexia2,056
  • pain1,833
  • dizziness1,622
  • vomiting1,562
  • pneumonia1,516
  • rash1,458
  • dyspnoea1,446
  • asthenia1,337
  • acute kidney injury1,216

Reports by year received

View as table
YearReports
2004708
2005798
2006898
20071,057
20081,190
20091,149
20101,173
20111,241
20121,500
20131,127
20141,205
20151,893
20162,107
20171,692
20181,881
20192,199
20202,361
20212,984
20224,618
20234,268
20244,135
20253,689
20262,382

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,007,902 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
acute kidney injurySignal1,2163.63.42,317
pyrexiaSignal2,0562.72.62,244
pneumoniaSignal1,5162.12.0923
asthenia1,3371.61.5320
nausea2,7831.61.5649
diarrhoea2,2611.61.5515
fatigue2,6781.61.5566
rash1,4581.51.4266
vomiting1,5621.51.4276
headache2,0711.51.4358
dizziness1,6221.51.4258
pain1,8331.41.3177
off label use2,4801.31.2167
dyspnoea1,4461.21.133
drug ineffective2,8021.00.93

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.